Association between serum 25-hydroxyvitamin D and serum sex steroid hormones among men in NHANES

Clinical Endocrinology

Volumn 85, Issue 2, 2016, Pages 258-266

  Anic, Gabriella M ^a   Albanes, Demetrius ^a   Rohrmann, Sabine ^b   Kanarek, Norma ^c,d   Nelson, William G ^c,d,e   Bradwin, Gary ^f   Rifai, Nader ^f   McGlynn, Katherine A ^a   Platz, Elizabeth A ^c,d,e   Mondul, Alison M ^g  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f BOSTON CHILDREN S HOSPITAL   (United States)

^g UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ANDROSTANEDIOL; ESTRADIOL; GLUCURONIDE; PROSTATE SPECIFIC ANTIGEN; SEX HORMONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; ARTICLE; ASSOCIATION; BODY FAT; CROSS-SECTIONAL STUDY; ESTRADIOL BLOOD LEVEL; ETHNICITY; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RACE; TESTOSTERONE BLOOD LEVEL; VITAMIN BLOOD LEVEL;

EID: 84978193694     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.13062     Document Type: Article

References (35)

1. Holick, M.F. (2009) Vitamin D status: measurement, interpretation, and clinical application. Annals of Epidemiology, 19, 73–78.
2. Gandini, S., Boniol, M., Haukka, J. et al. (2011) Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. International Journal of Cancer, 128, 1414–1424.
3. Mohr, S.B., Gorham, E.D., Alcaraz, J.E. et al. (2011) Serum 25-hydroxyvitamin D and prevention of breast cancer: pooled analysis. Anticancer Research, 31, 2939–2948.
4. Ahonen, M.H., Tenkanen, L., Teppo, L. et al. (2000) Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland). Cancer Causes and Control, 11, 847–852.
5. Corder, E.H., Guess, H.A., Hulka, B.S. et al. (1993) Vitamin D and prostate cancer: a prediagnostic study with stored sera. Cancer Epidemiology, Biomarkers and Prevention, 2, 467–472.
6. Xu, Y., Shao, X., Yao, Y. et al. (2014) Positive association between circulating 25-hydroxyvitamin D levels and prostate cancer risk: new findings from an updated meta-analysis. Journal of Cancer Research and Clinical Oncology, 140, 1465–1477.
7. Roddam, A.W., Allen, N.E., Appleby, P. et al. (2008) Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies. Journal of the National Cancer Institute, 100, 170–183.
8. Sharifi, N., Gulley, J.L. & Dahut, W.L. (2005) Androgen deprivation therapy for prostate cancer. JAMA, 294, 238–244.
9. Thompson, I.M., Goodman, P.J., Tangen, C.M. et al. (2003) The influence of finasteride on the development of prostate cancer. New England Journal of Medicine, 349, 215–224.
10. Andriole, G.L., Bostwick, D.G., Brawley, O.W. et al. (2010) Effect of dutasteride on the risk of prostate cancer. New England Journal of Medicine, 362, 1192–1202.
11. Nimptsch, K., Platz, E.A., Willett, W.C. et al. (2012) Association between plasma 25-OH vitamin D and testosterone levels in men. Clinical Endocrinology, 77, 106–112.
12. Wehr, E., Pilz, S., Boehm, B.O. et al. (2010) Association of vitamin D status with serum androgen levels in men. Clinical Endocrinology, 73, 243–248.
13. Pilz, S., Frisch, S., Koertke, H. et al. (2011) Effect of vitamin D supplementation on testosterone levels in men. Hormone and Metabolic Research, 43, 223–225.
14. Lee, D.M., Tajar, A., Pye, S.R. et al. (2012) Association of hypogonadism with vitamin D status: the European Male Ageing Study. European Journal of Endocrinology, 166, 77–85.
15. Hammoud, A.O., Meikle, A.W., Peterson, C.M. et al. (2012) Association of 25-hydroxy-vitamin D levels with semen and hormonal parameters. Asian Journal of Andrology, 14, 855–859.
16. Lerchbaum, E., Pilz, S., Trummer, C. et al. (2014) Serum vitamin D levels and hypogonadism in men. Andrology, 2, 748–754.
17. Peskoe, S.B., Joshu, C.E., Rohrmann, S. et al. (2015) Circulating total testosterone and PSA concentrations in a nationally representative sample of men without a diagnosis of prostate cancer. Prostate, 75, 1167–1176.
18. Vermeulen, A., Verdonck, L. & Kaufman, J.M. (1999) A critical evaluation of simple methods for the estimation of free testosterone in serum. Journal of Clinical Endocrinology and Metabolism, 84, 3666–3672.
19. Sodergard, R., Backstrom, T., Shanbhag, V. et al. (1982) Calculation of free and bound fractions of testosterone and estradiol-17 beta to human plasma proteins at body temperature. Journal of Steroid Biochemistry, 16, 801–810.
20. Looker, A.C., Dawson-Hughes, B., Calvo, M.S. et al. (2002) Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. Bone, 30, 771–777.
21. Deng, X., Song, Y., Manson, J.E. et al. (2013) Magnesium, vitamin D status and mortality: results from US National Health and Nutrition Examination Survey (NHANES) 2001 to 2006 and NHANES III. BMC Medicine, 11, 187.
22. National Center for Health Statistics. Available from: http://wwwn.cdc.gov/Nchs/Nhanes/2001-2002/L06VID_B.htm (accessed 04 June 2015).
23. Saraiya, M., Kottiri, B.J., Leadbetter, S. et al. (2005) Total and percent free prostate-specific antigen levels among U.S. men, 2001–2002. Cancer Epidemiology, Biomarkers and Prevention, 14, 2178–2182.
24. Chumlea, W.C., Guo, S.S., Kuczmarski, R.J. et al. (2002) Body composition estimates from NHANES III bioelectrical impedance data. International Journal of Obesity and Related Metabolic Disorders, 26, 1596–1609.
25. Gunter, E.W., Lewis, B.G. & Koncikowski, S.M. (1996) Laboratory Procedures Used for the Third National Health and Nutrition Examination Survey (NHANES III), 1988–1994. National Center for Health Statistics, Hyattsville, MD.
26. Institute of Medicine (2010) Dietary Reference Intakes for Calcium and Vitamin D. National Academies Press, Washington DC.
27. Kristal, A.R., Till, C., Song, X. et al. (2014) Plasma vitamin D and prostate cancer risk: results from the Selenium and Vitamin E Cancer Prevention Trial. Cancer Epidemiology, Biomarkers and Prevention, 23, 1494–1504.
28. Murphy, A.B., Nyame, Y., Martin, I.K. et al. (2014) Vitamin D deficiency predicts prostate biopsy outcomes. Clinical Cancer Research, 20, 2289–2299.
29. Jackson, M.D., Tulloch-Reid, M.K., Lindsay, C.M. et al. (2015) Both serum 25-hydroxyvitamin D and calcium levels may increase the risk of incident prostate cancer in Caribbean men of African ancestry. Cancer Medicine, 4, 925–935.
30. Steck, S.E., Arab, L., Zhang, H. et al. (2015) Association between plasma 25-Hydroxyvitamin D, ancestry and aggressive prostate cancer among African Americans and European Americans in PCaP. PLoS One, 10, e0125151.
31. Park, S.Y., Cooney, R.V., Wilkens, L.R. et al. (2010) Plasma 25-hydroxyvitamin D and prostate cancer risk: the multiethnic cohort. European Journal of Cancer, 46, 932–936.
32. Blomberg, J.M. (2014) Vitamin D and male reproduction. Nature Reviews. Endocrinology, 10, 175–186.
33. Blomberg, J.M. (2012) Vitamin D metabolism, sex hormones, and male reproductive function. Reproduction, 144, 135–152.
34. Kinuta, K., Tanaka, H., Moriwake, T. et al. (2000) Vitamin D is an important factor in estrogen biosynthesis of both female and male gonads. Endocrinology, 141, 1317–1324.
35. Lundqvist, J., Norlin, M. & Wikvall, K. (2011) 1alpha,25-Dihydroxyvitamin D3 exerts tissue-specific effects on estrogen and androgen metabolism. Biochimica et Biophysica Acta, 1811, 263–270.